Issue No. 15
In Search of Better Parkinson’s TreatmentDate: January 12, 2012
Parkinson’s disease is a progressive neurological disorder that causes debilitating symptoms. Although treatment can improve quality of life, nothing can stop the disease’s progression. Yet.
Johns Hopkins is one of 21 centers participating in a study sponsored by the Michael J. Fox Foundation for Parkinson’s Research. The Parkinson’s Progression Markers Initiative is designed to identify Parkinson’s disease biomarkers, which are biological characteristics that can identify a disease or track its progression.
“We currently don’t have a way to change the course of Parkinson’s,” says neurologist Zoltan Mari, M.D., the principal investigator at Johns Hopkins. “Identifying good markers could revolutionize the way we treat the disease by helping us slow its progression.”
Johns Hopkins is recruiting people who have received a recent diagnosis of Parkinson’s disease, as well as people who do not have Parkinson’s (for the control). The study involves imaging tests and blood samples. For information on enrollment, contact Arita McCoy, R.N., B.S.N., at 410-955-2954 or firstname.lastname@example.org.
Watch “Updates in Medical Management and Surgical Options for Parkinson’s Disease” with Johns Hopkins Parkinson’s experts William Anderson, M.D., and Zoltan Mari, M.D. Visit hopkinsmedicine.org/healthseminars.